(0 items)
Small Medium Large | Print-Friendly Version of this Page  | Email this Page to a Friend
Skip Navigation Links
Press Releases
Hot Topics
Statements
Comments
Correspondence
White Papers
Contact Public Relations
AABB > Press Room > Recommendation on Chronic Fatigue Syndrome and Blood Donation

Recommendation on Chronic Fatigue Syndrome and Blood Donation 

The AABB Interorganizational Task Force on Xenotropic Murine Leukemia Virus-Related Virus reviewed the risk of transfusion transmission of XMRV by individuals with chronic fatigue syndrome (CFS). The task force presented its recommendations to the AABB Board of Directors, which approved an interim measure intended to prevent patients with a current or past diagnosis of CFS from donating blood or blood components. 

AABB released an Association Bulletin today recommending that, as an interim measure until further definitive data are available, its member blood collectors, through the use of donor information materials available at the donation site, actively discourage potential donors who have been diagnosed by a physician with CFS [also known as chronic fatigue and immune dysfunction syndrome (CFIDS) or myalgic encephalomyelitis (ME)] from donating blood or blood components.

The task force includes representatives from the blood community, patient advocacy representatives, XMRV subject matter experts and liaisons from several government agencies, including the Office of the Assistant Secretary for Health, the Centers for Disease Control and Prevention, the Food and Drug Administration and the National Institutes of Health. 

AABB member institutions are required to follow all federal regulations regarding donor eligibility. At present, there are no specific regulations for deferral of individuals with diseases or syndromes that have been linked to XMRV.

AABB appreciates all individuals who want to donate blood but strongly urges that only those who are eligible and healthy do so.

Last updated: June 18, 2010

 

 Resources

Home  |  Site Map  | AABB © 2014. All rights reserved. |  Privacy Statement  |  Terms of Use